Stock Track | Inspire Medical Systems Plunges 5.03% in Extended Trading on Disappointing 2026 Outlook

Stock Track02-12 11:42

Inspire Medical Systems' stock fell 5.03% during extended trading on Wednesday, as investors reacted negatively to the company's financial guidance for the coming year.

The medical technology firm reported strong fourth-quarter 2025 results, with revenue rising 12% year-over-year to $269.1 million, beating analyst expectations. However, the company's 2026 revenue outlook of $950 million to $1 billion fell short of the FactSet consensus estimate of $1.01 billion, representing a growth rate of just 4% to 10%.

While quarterly performance exceeded expectations, the market focused on the revised forward guidance, which signals potentially slower growth ahead. The company also provided adjusted EPS guidance of $1.85 to $2.35 for 2026, with investors weighing these projections against current valuation metrics.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment